Bernhard Englinger

1.5k total citations
28 papers, 699 citations indexed

About

Bernhard Englinger is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Bernhard Englinger has authored 28 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Bernhard Englinger's work include Fibroblast Growth Factor Research (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and RNA Interference and Gene Delivery (3 papers). Bernhard Englinger is often cited by papers focused on Fibroblast Growth Factor Research (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and RNA Interference and Gene Delivery (3 papers). Bernhard Englinger collaborates with scholars based in Austria, United States and Jordan. Bernhard Englinger's co-authors include Walter Berger, Christine Pirker, Petra Heffeter, Bernhard K. Keppler, Alessio Terenzi, Christian R. Kowol, Sushilla van Schoonhoven, Gerald Timelthaler, Lisa Mayr and Michael Grusch and has published in prestigious journals such as Chemical Reviews, Angewandte Chemie International Edition and Scientific Reports.

In The Last Decade

Bernhard Englinger

26 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernhard Englinger Austria	14	304	273	166	85	79	28	699
Carmen A. Widmer Switzerland	3	318 1.0×	320 1.2×	127 0.8×	91 1.1×	122 1.5×	3	698
Kushtrim Kryeziu Austria	15	344 1.1×	412 1.5×	185 1.1×	67 0.8×	61 0.8×	25	846
Diana Groza Austria	11	250 0.8×	266 1.0×	167 1.0×	74 0.9×	92 1.2×	15	585
Ada W.Y. Leung Canada	17	300 1.0×	275 1.0×	174 1.0×	57 0.7×	95 1.2×	30	720
Kaushik Banerjee India	16	174 0.6×	259 0.9×	132 0.8×	50 0.6×	58 0.7×	30	574
Ye Wu China	17	692 2.3×	268 1.0×	167 1.0×	88 1.0×	126 1.6×	54	1.2k
Li Ding China	15	434 1.4×	242 0.9×	139 0.8×	45 0.5×	71 0.9×	38	877
Xiaolin Xiong China	13	263 0.9×	140 0.5×	166 1.0×	103 1.2×	110 1.4×	33	706
Dongfan Song China	18	390 1.3×	353 1.3×	193 1.2×	148 1.7×	221 2.8×	32	910
Yi Man Eva Fung Hong Kong	17	636 2.1×	259 0.9×	313 1.9×	95 1.1×	63 0.8×	25	1.1k

Countries citing papers authored by Bernhard Englinger

Since Specialization

Citations

This map shows the geographic impact of Bernhard Englinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Englinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Englinger more than expected).

Fields of papers citing papers by Bernhard Englinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Englinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Englinger. The network helps show where Bernhard Englinger may publish in the future.

Co-authorship network of co-authors of Bernhard Englinger

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Englinger. A scholar is included among the top collaborators of Bernhard Englinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Englinger. Bernhard Englinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Mosca, Elena, Christine Pirker, Markus Schosserer, et al.. (2024). The tyrosine kinase inhibitor Nintedanib induces lysosomal dysfunctionality: Role of protonation-dependent crystallization processes. Chemico-Biological Interactions. 403. 111243–111243. 1 indexed citations

2.

Pirker, Christine, Ursula Lemberger, Reinhard Grausenburger, et al.. (2024). Clofarabine Has a Superior Therapeutic Window as compared to Gemcitabine in Preclinical Bladder Cancer Models. European Urology Oncology. 7(6). 1166–1170.

3.

Kresbach, Catena, Denise Obrecht, Katja von Hoff, et al.. (2024). Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology. Acta Neuropathologica. 147(1). 23–23. 1 indexed citations

4.

Szűcs, Miklós, István Kenessey, Walter Berger, et al.. (2024). Precision Oncology Approach for Urachal Carcinoma: A Clinical Case Report. International Journal of Molecular Sciences. 25(24). 13315–13315. 1 indexed citations

5.

Lemberger, Ursula, Sigurd Krieger, André Oszwald, et al.. (2024). Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer. European Urology Open Science. 71. 38–48.

6.

Lemberger, Ursula, Paweł Rajwa, Gerald Timelthaler, et al.. (2024). Low SMARCD3 expression is associated with poor prognosis in patients with prostate cancer. The Prostate. 85(2). 181–190. 1 indexed citations

7.

Pun, Matthew, Drew Pratt, Piyush Joshi, et al.. (2023). Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways. Acta Neuropathologica Communications. 11(1). 25–25. 18 indexed citations

8.

Witzigmann, Dominik, Philip Grossen, Cristina Quintavalle, et al.. (2021). Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma. Journal of Controlled Release. 334. 138–152. 4 indexed citations

9.

Peyrl, Andreas, Lisa Mayr, Bernhard Englinger, et al.. (2020). Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients. Acta Neuropathologica Communications. 8(1). 78–78. 31 indexed citations

10.

Pirker, Christine, Carina Dinhof, Bernhard Englinger, et al.. (2019). Subcellular Duplex DNA and G‐Quadruplex Interaction Profiling of a Hexagonal Pt^II Metallacycle. Angewandte Chemie International Edition. 58(24). 8007–8012. 44 indexed citations

11.

Pirker, Christine, Carina Dinhof, Bernhard Englinger, et al.. (2019). Subcellular Duplex DNA and G‐Quadruplex Interaction Profiling of a Hexagonal Pt^II Metallacycle. Angewandte Chemie. 131(24). 8091–8096. 9 indexed citations

12.

Kiakos, Konstantinos, Bernhard Englinger, Stephanie K. Yanow, et al.. (2018). Design, synthesis, nuclear localization, and biological activity of a fluorescent duocarmycin analog, HxTfA. Bioorganic & Medicinal Chemistry Letters. 28(8). 1342–1347. 5 indexed citations

13.

Castro, Silvia Alonso‐de, Alessio Terenzi, Sonja Hager, et al.. (2018). Biological activity of PtIV prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis. Scientific Reports. 8(1). 17198–17198. 33 indexed citations

14.

Röhrl, Clemens, Christine Pirker, Bernhard Englinger, et al.. (2018). Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins. Oncotarget. 9(39). 25661–25680. 15 indexed citations

15.

Englinger, Bernhard, Christine Pirker, Petra Heffeter, et al.. (2018). Metal Drugs and the Anticancer Immune Response. Chemical Reviews. 119(2). 1519–1624. 302 indexed citations

16.

Rodríguez-Carrasco, Yelko, Bernhard Englinger, Gerald Timelthaler, et al.. (2017). The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study. Toxins. 9(9). 258–258. 28 indexed citations

17.

Englinger, Bernhard, Maximilian J. Mair, Walter Miklos, et al.. (2017). Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance. British Journal of Cancer. 116(4). 489–500. 13 indexed citations

18.

Englinger, Bernhard, Sushilla van Schoonhoven, Alessio Terenzi, et al.. (2017). Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer. Journal of Experimental & Clinical Cancer Research. 36(1). 122–122. 52 indexed citations

19.

Englinger, Bernhard, Daniela Lötsch, Christine Pirker, et al.. (2016). Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression. Oncotarget. 7(31). 50161–50179. 18 indexed citations

20.

Miklos, Walter, Christian R. Kowol, Christine Pirker, et al.. (2015). Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance. Cancer Letters. 361(1). 112–120. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact